The Covenant Nobody Reads: Venture Debt Has Become the Load-Bearing Wall of the 2026 Disrupt 500
Photo by Photo by Romain Dancre on Unsplash on Unsplash
Venture debt used to be a rounding error in the startup capital stack — a bridge for companies between rounds, priced as an afterthought, negotiated in a week. In 2026 it is closer to a load-bearing wall. Of the 500 companies on this year's list, 186 disclose at least one active debt facility. The median facility size has roughly doubled since 2023, and the median time to first draw has shortened to fourteen months after a company's last equity round.
The reason is straightforward. Equity is expensive relative to 2021, and a flat or modestly down round is now a public event that resets employee strike prices, triggers investor protections, and consumes six months of founder attention. Debt does none of that. It buys time without resetting the price. What it also does, quietly, is transfer a meaningful share of control to a lender whose interests diverge from the equity holder's the moment growth decelerates.
The quiet line item
The 2026 Disrupt 500 submissions reveal three distinct uses of debt, and they carry very different risk profiles.
Working capital for hardware and marketplace businesses. Inventory, receivables, and float. This is the least controversial use and the easiest for a lender to underwrite, because the collateral is tangible and the repayment schedule maps to a cash cycle.
Runway extension ahead of a round. The company wants eighteen months instead of eleven, and wants to negotiate its next raise from a position of patience rather than need. This is the most common use in the dataset and the one most sensitive to timing. If the round slips two quarters past plan, the covenant math changes and the founder discovers that patience was rented, not owned.
Acquisition financing. Increasingly common. Companies on the list that bought smaller competitors in 2025 and 2026 frequently funded the cash portion with debt rather than a priced equity round, preserving ownership while consolidating a fragmented market. It is a sophisticated move and an unforgiving one: integration costs almost always exceed plan, and the lender's covenant does not care about synergy.
What US lenders are demanding in 2026
The terms have hardened. Across the facilities disclosed to our research team, the pattern is consistent.
Interest pricing has settled in a range that assumes the base rate stays where it is, with most facilities floating. Interest-only periods have shortened, typically running twelve to eighteen months before amortization begins. Warrant coverage — the equity kicker that makes venture debt economics work for the lender — now clusters around 1.0x to 1.3x the facility amount, with exercise prices usually set at the last round's valuation but occasionally at a discount to it.
The covenants are where the real shifts sit. Minimum liquidity tests are now near-universal: the borrower must maintain cash equal to a stated number of months of operating expense, often six. Quarterly revenue tests, measured against a plan negotiated at closing, appear in the majority of facilities. Material adverse change clauses remain broad and are the provision founders most consistently underestimate, because a MAC determination is subjective and a lender that wants its money back has a low bar to clear. Nearly every facility secures the lender against intellectual property and restricts additional indebtedness, and a growing share restrict acquisitions and require lender consent for changes in executive leadership.
Bridge or trap: two outcomes from the list
A cybersecurity company ranked in the upper third of the 2026 Disrupt 500 took a facility in early 2025 to fund a channel expansion. Revenue tested above plan for three quarters, the company raised an up round in 2026, and the debt was repaid early at a modest prepayment penalty. Total dilution avoided, by management's own estimate, was in the high single digits. That is the instrument working exactly as designed.
A logistics software company on the list took a comparable facility nine months later, at similar pricing. Revenue came in 11% below the covenant plan in the following two quarters — not because the product failed, but because two enterprise deals slipped into the next fiscal year. The lender invoked the revenue test, froze the undrawn portion, and required a cash sweep on collections. The company survived, but it raised its next round under duress, at a valuation its founders still decline to discuss on the record. The difference between the two outcomes was not the quality of the businesses. It was the distance between the covenant plan and the operating plan.
The questions a board should ask before signing
First, whether the covenant plan is the number the company will actually hit in a bad year, or the number management hopes to hit in a good one. The covenant should be set against the downside case with margin, not the base case.
Second, what triggers a MAC determination in practice, and what the lender's historical behavior has been. Ask other portfolio companies of that lender. This is a small market and the information is available.
Third, whether the company can service the debt from operating cash flow if the next round slips two quarters. If the answer depends on the round, the debt is not a bridge. It is a bet on the capital markets, made with the lender's money and the founder's equity.
Fourth, what the total cost is including warrants at a realistic exit valuation, not the last round valuation. The headline interest rate is rarely the expensive part.
The discipline debt imposes
Venture debt is neither prudent nor reckless in the abstract. It is a tool that converts a growth plan into a contractual obligation. The founders on this year's list who used it well share one habit: they treated the covenant schedule as the operating plan's floor and built their forecasts above it. The ones who struggled treated the covenant as a formality and their own forecast as the truth. In a market where the cost of equity has not fallen as fast as founders hoped, that distinction is now worth more than a valuation mark.